Platelet Rich Plasma and Its Growth Factors: The State of the Art

  • José F. LanaEmail author
  • Adam Weglein
  • Eduardo Vicente
  • Amanda G. M. Perez
  • Ana A. Rodrigues
  • Ângela C. M. Luzo
  • Maria H. A. Santana
  • William D. Belangero
Part of the Lecture Notes in Bioengineering book series (LNBE)


This study aims to offer a general idea of the current progress and discussions about the aspects of technical preparation and biological foundation of PRP for clinical application. We seek to gather the best therapeutic indications that have a scientific foundation on the use of this new tool of Regenerative Medicine. The articles of this study were acquired from the leading data bases of medical literature.


Anterior Cruciate Ligament Total Knee Arthroplasty Anterior Cruciate Ligament Reconstruction Patellar Tendon Platelet Rich Plasma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Acosta-Feria M, Infante-Cossío P, Hernández-Guisado JM et al (2006) Obliteración del seno frontal mediante injerto de tibia y plasma rico en plaquetas para el tratamiento de la osteomielitis crônica. Neurocirugía 17(4):351–356Google Scholar
  2. Ali SF (2012) Platelet activation in stored platelet concentrates: comparison of two methods preparation. J Blood Disord Transfus 1(1):15–19Google Scholar
  3. Alsousou J, Thompson M, Hulley P, Noble A, Willett K (2009) The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery. J Bone Joint Surg Br 91(8):987–996Google Scholar
  4. Ambroziak M, Pedzisz P, Górecki A et al (2006) Revision anterior cruciate ligament reconstruction using a PDGF-saturated frozen radiation-sterilised allogenic patellar ligament graft: a case report. Arthrosc Joint Surg 2(3):30–36Google Scholar
  5. Anitua E (1999) Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implant 14(4):529–553Google Scholar
  6. Anitua E, Andia I, Ardanza B et al (2004) Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91(1):4–15Google Scholar
  7. Anitua E, Andia I, Sanchez M et al (2005) Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF productions by human tendon cells in culture. J Orthop Res 23:281–286Google Scholar
  8. Anitua E, Sánchez M, Orive G et al (2007) The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 28(31):4551–4560Google Scholar
  9. Anitua E, Aguirre JJ, Algorta J et al (2008) Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater 84(2):415–421Google Scholar
  10. Anitua E, Sánchez M, de la Fuente M et al (2009a) Relationship between investigative biomarkers and radiographic grading in patients with knee osteoarthritis. Int J Rheumatol [Epub 2009 Apr 6]Google Scholar
  11. Anitua E, Sánchez M, Orive G et al (2009b) Shedding light in the controversial terminology for platelet rich products. J Biomed Mater Res A 90(4):1262–1263Google Scholar
  12. Arnoczky SP, Warren RF (1983) The microvasculature of the meniscus and its response to injury. An experimental study in the dog. Am J Sports Med 11:131–141Google Scholar
  13. Aspenberg P, Virchenko O (2004) Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand 75(1):93–99Google Scholar
  14. Barber FA, Hrnack SA, Snyder SJ, Hapa O (2011) Rotator cuff repair healing influenced by platelet-rich plasma construct augmentation. Arthroscopy 27(8):1029–1035Google Scholar
  15. Barrow CR, Pomeroy GC (2005) Enhancement of syndesmotic fusion rates in total ankle arthroplasty with the use of autologous platelet concentrate. Foot Ankle Int 26(6):458–461Google Scholar
  16. Bendinelli P, Matteucci E, Dogliotti G et al (2010) Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-κB inhibition via HGF. J Cell Physiol 225(3):757–766Google Scholar
  17. Bennett NT, Schultz GS (1993a) Growth factors and wound healing. Part II. Role in normal and chronic wound healing. Am J Surg 166(1):74–81Google Scholar
  18. Bennett NT, Schultz GS (1993b) Growth factors and wound healing: Biochemical properties of growth factors and their receptors. Am J Surg 165(6):728–737Google Scholar
  19. Bennett SP, Griffiths GD, Schor AM et al (2003) Growth factors in the treatment of diabetic foot ulcers. Br J Surg 90(2):133–146Google Scholar
  20. Bergel S (1909) Uber Wirkung des Fibrins. Dtsch Med Wochenschr 35:633–665Google Scholar
  21. Berghoff MJ, Pietrzak WS, Rhodes RD (2006) Platelet-rich plasma application during closure following total knee arthroplasty. Orthopedics 29(7):590–598Google Scholar
  22. Bibbo C, Bono CM, Lin SS (2005) Union rates using autologous platelet concentrate alone and with bone graft in high-risk foot and ankle surgery patients. J Surg Orthop Adv 14(1):17–22Google Scholar
  23. Bielecki T, Gazdzik TS, Szczepanski T (2008) Benefit of percutaneous injection of autologous platelet-leukocyte-rich gel in patients with delayed union and nonunion. Eur Surg Res 40:289–296Google Scholar
  24. Biggi F, Caloprisco G, Scorrano A (2004) Autologous platelet gel in orthopaedics and traumatology (3-year experience). J Bone Joint Surg 87(Suppl 2):173Google Scholar
  25. Blunk T, Sieminski AL, Gooch KJ et al (2002) Differential effects of growth factors on tissue-engineered cartilage. Tissue Eng 8(1):73–84Google Scholar
  26. Boros P, Miller CM (1995) Hepatocyte growth factor: a multifunctional cytokine. Lancet 345(8945):239–5Google Scholar
  27. Boss WK, Usal H, Chernoff G et al (2000) Autologous cultured fibroblasts as cellular therapy in plastic surgery. Clin Plast Surg 27(4):613–626Google Scholar
  28. Buda R, Vannini F, Battaglia M et al (2011) My experience with PRP 3. ICRS Newslett 13:32Google Scholar
  29. Carter MJ, Fylling CP, Li WW, de Leon J, Driver VR, Serena TE, Wilson J (2011a) Analysis of run-in and treatment data in a wound outcomes registry: clinical impact of topical platelet-rich plasma gel on healing trajectory. Int Wound J 8(6):638–650Google Scholar
  30. Carter MJ, Fylling CP, Parnell LK (2011b) Use of platelett rich plasma gel on woundhealing: a systematic review and meta-analysis. Eplasty 11:e38 [Epub]Google Scholar
  31. Castricini R, Longo UG, De Benedetto M et al (2011) Platelet rich plasma augmentation for arthroscopic rotator cuff repair: a randomized controlled trial. Am J Sports Med 3:258–265Google Scholar
  32. Centeno CJ, Busse D, Kisiday J et al (2008a) Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells, platelet lysate and dexamethasone. Pain Physician 11(3):343–353Google Scholar
  33. Centeno CJ, Busse D, Kisiday J et al (2008b) Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Med Hypotheses 71(6):900–908Google Scholar
  34. Cervelli V, Gentile P, Grimaldi M (2009) Regenerative surgery: use of fat grafting combined with platelet-rich plasma for chronic lower-extremity ulcers. Aesth Plast Surg 33:340–345Google Scholar
  35. Cervelli V, Lucarini L, Spallone D et al (2011) Use of platelet-rich plasma and hyaluronic acid in the loss of substance with bone exposure. Adv Skin Wound Care 24(4):176–181Google Scholar
  36. Cerza F, Carnì S, Carcangiu A, Di Vavo I, Schiavilla V, Pecora A, De Biasi G, Ciuffreda M (2012) Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med 40(12):2822–2827Google Scholar
  37. Chang CH, Lin FH, Kuo TF et al (2005) Cartilage tissue engineering. Biomed Eng Appl Basis Comm 17(2):1–11MathSciNetGoogle Scholar
  38. Chang SH, Hsu YM, Wang YJ et al (2009) Fabrication of pre-determined shape of bone segment with collagen-hydroxyapatite scaffold and autogenous platelet-rich plasma. J Mater Sci Mater Med 20(1):23–31Google Scholar
  39. Choukroun J, Adda F, Schoeffler C et al (2001) Une opportunité en paro-implantologie: le PRF. Implantodontie 41:55–62Google Scholar
  40. Cieslik-Bielecka A, Gazdzik TS, Bielecki TM et al (2007) Why the platelet-rich gel has antimicrobial activity? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(3):303–305Google Scholar
  41. Cieslik-Bielecka A, Bielecki T, Gazdzik TS et al (2009) Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury. Transfus Apheres Sci 41(1):9–12Google Scholar
  42. Clark RAF (1996) Overview and general considerations of wound repair. In: Clark RAF (ed) The molecular and cellular biology of wound repair. Plenum Press, New York, pp 3–50Google Scholar
  43. Coetzee JC, Pomeroy GC, Watts JD et al (2005) The use of autologous concentrated growth factors to promote syndesmosis fusion in the agility total ankle replacement. A preliminary study. Foot Ankle In 26(10):840–846Google Scholar
  44. Cole BJ, Seroyer ST, Filardo G (2010) Platelet-rich plasma: where are we now and where are we going? Sports Health 2(3):203–210Google Scholar
  45. Crane D, Everts PAM (2008) Platelet rich plasma (PRP) matrix grafts. Pract Pain Manage 8(1):11–26Google Scholar
  46. Creaney L, Hamilton B (2008) Growth factor delivery methods in the management of sports injuries: the state of play. Br J Sports Med 42(5):314–320Google Scholar
  47. Creaney L, Wallace A, Curtis M et al (2011) Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med 45(12):966–971Google Scholar
  48. Crovetti G, Martinelli G, Issi M et al (2004) Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci 30(2):145–151Google Scholar
  49. D’Elia CO, Rezende MU, Bitar AC et al (2009) O uso do plasma rico em plaquetas associado ao aspirado de medular óssea na osteotomia tibial tipo Puddu. Rev Bras Ortop 44(6):508–512Google Scholar
  50. Dailiana ZH, Kantzanou M, Damdounis A et al (2003) Augmentation of osteogenesis with the use of autologous growth factors (agf) a preliminary clinical and laboratory report. Poster #0379. In: 49th Annual Meeting of the Orthopaedic Research Society, New Orleans, 2003Google Scholar
  51. Dallari D, Savarino L, Stagni C et al (2007) Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am 89(11):2413–2420Google Scholar
  52. Dang ABC, Kuo AC, Kim HT (2009) Future of cartilage resurfacing procedures: a case for growth factors. Tech Knee Surg 8:2–6Google Scholar
  53. Danielsen PL, Agren MS, Jorgensen LN (2010) Platelet-rich fibrin versus albumin in surgical wound repair: a randomized trial with paired design. Ann Surger 251(5):825–831Google Scholar
  54. de Almeida AM, Demange MK, Sobrado MF, Rodrigues MB, Pedrinelli A, Hernandez AJ (2012) Patellar tendon healing with platelet-rich plasma: a prospective randomized controlled trial. Am J Sports Med 40(6):1282–1288. doi: 10.1177/0363546512441344 Google Scholar
  55. de Mos M, van der Windt A, Jahr H et al (2008) Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med 36(6):1171–1178Google Scholar
  56. de Vos RJ, Weir A, van Schie HTM (2010) Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA 303(2):144–149Google Scholar
  57. de Vries RA, de Bruin M, Marx JJ et al (1993) Viability of platelets collected by apheresis versus the platelet-rich plasma technique: a direct comparison. Transfus Sci 14(4):391–398Google Scholar
  58. Dellinger R, Britton C (unpublished) Autologous platelet grafting procedure—a new approach to healing chronic wounds and comparison between current therapies. Unpublished Monograph White Paper. Acessed 18 Aug 2013
  59. Delos D, Rodeo SA (2011) Cartilage & PRP. ICRS Newsl 13:23Google Scholar
  60. Dohan Ehrenfest DM, Choukroun J, Diss A et al (2006a) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:e37–e44Google Scholar
  61. Dohan Ehrenfest DM, Choukroun J, Diss A et al (2006b) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates?. Oral Surg. Oral Med. Oral Pathol Oral Radiol Endod 101:e51–e55Google Scholar
  62. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T (2009) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27(3):158–167Google Scholar
  63. Dohan Ehrenfest DM, Bielecki T, Del Corso M et al (2010) Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism. J Biomed Mater Res A 95(4):1280–1282Google Scholar
  64. Dohan Ehrenfest DM, Bielecki T, Mishra A et al (2011) In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes. Curr Pharm Biotechnol [Epub ahead of print]Google Scholar
  65. Dohan Ehrenfest DM, Bielecki T, Jimbo R, Barbe G, Del Corso M, Inchingolo F, Sammartino G (2012) Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol 13(7):1145–1152Google Scholar
  66. Drengk A, Zapf A, Stürmer EK et al (2009) Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 189(5):317–326Google Scholar
  67. Driver VR, Hanft J, Fylling CP et al (2006) A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 52(6):68–70, 72, 74 passimGoogle Scholar
  68. Duranti F, Salti G, Bovani B et al (1998) Injectable hyaluronic acid gel for soft tissue augmentation: a clinical and histologic study. Dermatol Surg 24(12):1317–1325Google Scholar
  69. Dutto E, Ferrero M, Bertolini M et al (2005) The employment of autologous platelet gel in upper limb surgery: biological principles and preliminary results. J Bone Joint Surg Br 87-B(SUPP_II, 201)Google Scholar
  70. Ekbäck G, Ryttberg L, Axelsson K et al (2000) Preoperative platelet-rich plasmapheresis and emodilution with an autotransfusion device in total hip replacement surgery. J Clin Apher 15(4):256–261Google Scholar
  71. Ekbäck G, Edlund B, Smolovicz A et al (2002) The effects of platelet apheresis in total hip replacement surgery on platelet activation. Acta Anaesthesiol Scand 46(1):68–73Google Scholar
  72. El-Sharkawy H, Kantarci A, Deady J et al (2007) Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol 78(4):661–669Google Scholar
  73. Engebretsen L, Steffen K, Alsousou J et al (2010) IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med 44(15):1072–1081Google Scholar
  74. Engert JC, Berglund EB, Rosenthal N (1996) Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J Cell Biol 135(2):431–440Google Scholar
  75. Eppley BL, Woodell JE, Higgins J (2004) Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing. Plast Reconstr Surg 114(6):1502–1508Google Scholar
  76. Everts PA, Hoffmann J, Weibrich G et al (2006a) Differences in platelet growth factor release and leukocyte kinetics during autologous platelet gel formation. Transfus Medicine 16(5):363–368Google Scholar
  77. Everts PAM, Devilee RJJ, Brown-Mahoney CH et al (2006b) Platelet gel and fibrin sealant reduce allogenic blood transfusions and in total knee arthroplasty. Acta Anaesth Scand 50:593–599Google Scholar
  78. Everts PAM, Knape JTA, Weibrich G et al (2006c) Platelet rich plasma and platelet gel. J Extra Corp Techn 38(2):174–187Google Scholar
  79. Everts PA, Devilee RJ, Brown Mahoney C et al (2007a) Exogenous application of platelet-leukocyte gel during open subacromial decompression contributes to improved patient outcome: a prospective randomized double-blind study. Eur Surg Res 40(2):203–210Google Scholar
  80. Everts PA, Devilee RJ, Oosterbos CJ et al (2007b) Autologous platelet gel and fibrin sealant enhance the efficacy of total knee arthroplasty: improved range of motion, decreased length of stay and a reduced incidence of arthrofibrosis. Knee Surg Sports Traumatol Arthrosc 15(7):888–894Google Scholar
  81. Everts PAM, van Zundert A, Schönberger JPAM et al (2008) What do we use: platelet-rich plasma or platelet-leukocyte gel? J Biomed Mater Res A 85(4):1135–1136Google Scholar
  82. Fathke C, Wilson L, Hutter J et al (2004) Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells 22(5):812–822Google Scholar
  83. Feiz-Erfan I, Harrigan M, Sonntag VK et al (2007) Effect of autologous platelet gel on early and late graft fusion in anterior cervical spine surgery. J Neurosurg Spine 7(5):496–502Google Scholar
  84. Figueroa D, Melean P, Calvo R et al (2010) Magnetic resonance imaging evaluation of the integration and maturation of semitendinosus-gracilis graft in anterior cruciate ligament reconstruction using autologous platelet concentrate. Arthroscopy 26(10):1318–1325Google Scholar
  85. Filardo G, Kon E, Buda R, Timoncini A, Di Martino A, Cenacchi A, Fornasari PM, Giannini S, Marcacci M (2011) Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 19(4):528–535. doi: 10.1007/s00167-010-1238-6 [Epub]Google Scholar
  86. Filardo G, Kon E, Di Martino A, Di Matteo B, Merli ML, Cenacchi A, Fornasari PA, Marcacci (2012) Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord 13:229Google Scholar
  87. Flamini S, Di Francesco A, Colafarina O et al (2007) Autologous platelet gel for delayed union of tibial shaft treated with intramedullary nailing. J Orthopaed Traumatol 8(1):1–5Google Scholar
  88. Fortier L, Nixon A, Mohammed H et al (1997) Altered biological activity of equine chondrocytes cultured in a three-dimensional fibrin matrix and supplemented with transforming growth factor beta-1. Am J Vet Res 58(1):66–70Google Scholar
  89. Fortier LA, Cole BJ, Bajaj S et al (2011) Optimizing platelet rich plasma preparation to maximize tissue repair and minimize tissue degeneration. ICRS Newslett 13:39Google Scholar
  90. Franchini M, Dupplicato P, Ferro I et al (2005) Efficacy of platelet gel in reconstructive bone surgery. Orthopedics 28(2):161–163Google Scholar
  91. Francone CA, Jacob SW, Lossow WJ (1990) Anatomia e Fisiologia Humana, 5th edn. Editora Guanabara, Rio de JaneiroGoogle Scholar
  92. Fu X, Li X, Cheng B et al (2005) Engineered growth factors and cutaneous wound healing: success and possible questions in the past 10 years. Wound Rep Regen 13(2):122–130Google Scholar
  93. Galasso O, Mariconda M, Romano G et al (2008) Expandable intramedullary nailing and platelet rich plasma to treat long bone non-unions. J Orthopaed Traumatol 9(3):129–134Google Scholar
  94. Gandhi A, Van Gelderen J, Berberian WS et al (2003) Platelet releasate enhances healing in pa-tients with a non-union. Poster presentation #0492. In: 49th Annual Meeting of the Orthopaedic Research Society, New Orleans, 2003Google Scholar
  95. Gandhi A, Bibbo C, Pinzur M et al (2005) The role of platelet-rich plasma in foot and ankle surgery. Foot Ankle Clin 10(4):621–637Google Scholar
  96. Gandhi A, Dumas C, O’Conner JP et al (2006) The effects of local platelet rich plasma on diabetic fracture healing. Bone 38(4):540–546Google Scholar
  97. Ganio C, Tenewitz FE, Wilson RC et al (1993) The treatment of chronic nonhealing wounds using autologo platelet-derived growth factors. J Foot Ankle Surg 32(3):263–267Google Scholar
  98. Gardner MJ, Demetrakopoulos D, Klepchick PR et al (2007) The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty: an analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop 31(3):309–313Google Scholar
  99. Gaweda M, Tarczynska W, Krzyzanowskia C (2010) Treatment of Achilies tendinopathy with platelet-rich plasma. Int J Sports Med 31(8):577–583Google Scholar
  100. Gibble JW, Ness PM (1990) Fibrin Glue: the perfect operative sealant? Transfusion 30(8):741–747Google Scholar
  101. Gobbi A (2010) New technology: bio-orthopaedics. J Clin Rehabil Tissue Eng Res 14:1–4Google Scholar
  102. Gobbi A, Somanna MS, Karnatzikos G (2011) Platelet rich plasma (PRP) in osteoarthritis: our early experience. ICRS Newslett 13:29Google Scholar
  103. Gobbi A, Karnatzikos G, Mahajan V, Malchira S (2012) Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health 4(2):162–172Google Scholar
  104. Goldman R (2004) Growth factors and chronic wound healing: past, present, and future. Avd Skin Wound Care 17(1):24–35Google Scholar
  105. Gooch KJ, Blunk T, Courter DL et al (2002) Bone morphogenetic proteins-2, -12, and -13 modulate in vitro development of engineered cartilage. Tissue Eng 8:591–601Google Scholar
  106. Gosens T (2011) Platelet Rich Plasma PRP—Evidence or Hype? ICRS Newslett 13:22Google Scholar
  107. Gosens T, Sluimer J (2011) Prospective randomized study on the effect of autologous platelets injection in lateral epicondylitis compared with corticosteroid injection. Accessed 16 May 2013
  108. Gruber HE, Fisher EC Jr, Desai B, Stasky AA, Hoelscher G, Hanley EN (1997) Human intervertebral disc cells from the annulus: three-dimensional culture in agarose or alginate and responsiveness to TGF-beta1. Jr Exp Cell Res 235(1):13–21Google Scholar
  109. Gruber HE, Norton HJ, Hanley EN (2000) Anti-apoptotic effects of IGF-1 and PDGF on human intervertebral disc cells in vitro. J Spine (Phila Pa 1976) 25(17):2153–2157Google Scholar
  110. Gustafsson T, Kraus WE (2001) Exercise-induced angiogenesis-related growth and transcription factors in skeletal muscle, and their modification in muscle pathology. Front Biosci 6:D75–D89Google Scholar
  111. Guyton AC, Hall JE (1997) Tratado de Fisiologia Médica, 9th edn. Guanabara-Koogan, Rio de JaneiroGoogle Scholar
  112. Haisch A, Loch A, David J et al (2000) Preparation of a pure autologous biodegradable fibrin matrix for tissue engineering. Med Biol Eng Comput 38:686–689Google Scholar
  113. Hamid MS, Mohamed Ali MR, Yusof A, George J (2012) Platelet-rich plasma (PRP): an adjuvant to hasten hamstring muscle recovery. A randomized controlled trial protocol (ISCRTN66528592). BMC Musculoskelet Disord 6(13):138. doi:  10.1186/1471-2474-13-138
  114. Hammond JW, Hinton RY, Curl LA et al (2009) Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sports Med 37(6):1135–1142Google Scholar
  115. Hampton MB, Kettle AJ, Winterbourn CC (1996) Involvement of superoxide and myeloperoxidase in oxygen-dependent killing of Staphylococcus aureus by neutrophils. Infect Immun 64(9):3512–3517Google Scholar
  116. Hanson SR, Harker LA (1996) Blood coagulation and blood-materials interactions. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (ed) Biomaterials science. An introduction to materials in medicine. Academic Press, San Diego, pp 193–199Google Scholar
  117. Harmon KG (2010) Muscle injuries and PRP: what does the science say? Br J Sports Med 44(9):616–617Google Scholar
  118. Harmon K, Hanson R, Bowen J et al (2011) Guidelines for the use of platelet rich plasma. The International Cellular Medical Society. Accessed 01 Jun 2011
  119. He L, Lin Y, Hu X et al (2009) A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108(5):707–713Google Scholar
  120. Hechtman KS, Uribe JW, Botto-Vandemden A et al (2011) Platelet-rich plasma injection reduces pain in patients with recalcitrant epicondylitis. Orthopedics 34(2):92Google Scholar
  121. Hendrickson D, Nixon A, Grande D et al (1994) Chondrocyte-fibrin matrix transplants for resurfacing extensive articular cartilage defects. J Orthop Res 12(4):485–497Google Scholar
  122. Henning CE, Lynch MA, Yearout KM et al (1990) Arthroscopic meniscal repair using an exogenous fibrin clot. Clin Orthop Relat Res 252:64–72Google Scholar
  123. Henrique Jones J, Virgolino M (2011) Microfactures in combination with pletelet-rich plasma, in small knee chondral defects, using a new application arthroscopic technique. ICRS Newslett 13:27Google Scholar
  124. Hom DB, Linzie BM, Huang TC (2007) The healing effects of autologous platelet gel on acute human skin wounds. Arch Facial Plast Surg 9(3):174–183Google Scholar
  125. Hsu CW, Yuan K, Tseng CC (2009) The negative effect of platelet-rich plasma on the growth of human cells is associated with secreted thrombospondin-1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107(2):185–192Google Scholar
  126. Hu X, Wang C, Rui Y (2012) An experimental study on effect of autologous platelet-rich plasma on treatment of early intervertebral disc degeneration. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 26(8):977–983Google Scholar
  127. Illingworth KD, Musahl V, Lorenz SGF et al (2010) Use of fibrin clot in the knee. Oper Tech Orthop 20(2):90–97Google Scholar
  128. Ishimura M, Tamai S, Fujisawa Y (1991) Arthroscopic meniscal repair with fibrin glue. Arthroscopy 7(2):171–181Google Scholar
  129. Kawabe N, Yoshinao M (1991) The repair of fullthickness articular cartilage defects. Immune responses to reparative tissue formed by allogeneic growth plate chondrocyte implants. Clin Orthop 268:279–293Google Scholar
  130. Kawasumi M, Kitoh H, Siwicka KA et al (2008) The effect of the platelet concentration in platelet-rich plasma gel on the regeneration of bone. J Bone Joint Surg Br 90(7):966–972Google Scholar
  131. Kazakos K, Lyras DN, Verettas D et al (2009) The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury 40(8):801–805Google Scholar
  132. King D (1936) The healing of semilunar cartilages. J Bone Joint Surg 18(2):333–342Google Scholar
  133. Kirkaldy-Willis WH, Wedge JH, Yong-Hing K, Reilly J (1978) Pathology and pathogenesis of lumbar spondylosis and stenosis. Spine (Phila Pa 1976) 3(4):319–328Google Scholar
  134. Kitoh H, Kitakoji T, Tsuchiya H et al (2004) Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis: a preliminary result of three cases. Bone 35(4):892–898Google Scholar
  135. Klinger MH, Jelkmann W (2002) Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22(9):913–922Google Scholar
  136. Knighton DR, Hunt TK, Thakral KK et al (1982) Role of platelets and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis. Ann Surg 196(4):379–388Google Scholar
  137. Knighton DR, Doucette M, Fiegel VD et al (1988) The use of platelet derived wound healing formula in human clinical trials. Prog Clin Biol Res 266:319–329Google Scholar
  138. Knighton DR, Ciresi KF, Fiegel VD et al (1990) Stimulation of repair in chronic non healing cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 170(1):56–60Google Scholar
  139. Ko GD (2010) Platelet-Rich Plasma Prolotherapy for Low Back Pain Caused by Sacroiliac Joint Laxity. PPM Communications. Accessed 16 May 2013
  140. Kon E, Filardo G, Delcogliano M et al (2009) Platelet-rich plasma: new clinical application. A pilot study for treatment of jumper’s knee. Injury Int J Care Injured 40(6):598–603Google Scholar
  141. Kon E, Buda R, Filardo G et al (2010) Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 18(4):472–479Google Scholar
  142. Kon E, Filardo G, Marcacci M (2011) Platelet-rich plasma (PRP) is under investigation in innumerable preclinical studies or even used in clinical praterogeneous applications. ICRS Newslett 13:24Google Scholar
  143. Kosai K, Matsumoto K, Fukanoshi H et al (1990) Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 30(1):151–159Google Scholar
  144. Kovacevic D, Rodeo SA (2008) Biological augmentation of rotator cuff tendon repair. Clin Orthop Relat Res 466(3):622–633Google Scholar
  145. Krijgsveld J, Zaat SA, Meeldijk J et al (2000) Thrombocidins, microbicidal proteins from human blood platelets, are c-terminal deletion products of CXC chemokines. J Biol Chem 275(27):20374–20381Google Scholar
  146. Krupski WC, Reilly LM, Perez S et al (1991) A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. J Vasc Surg 14(4):526–532Google Scholar
  147. Kubota S, Kawata K, Yanagita T et al (2004) Abundant retention and release of connective tissue growth factor (CTGF/CCN2) by platelets. J Biochem 136(3):279–282Google Scholar
  148. Lafeber F, van Meegeren M, Nieuwenhuizen (2011) Plasma and whole blood are damaging to cartilage. ICRS Newslett 13:38Google Scholar
  149. Leão MP, Magini RS (2004) Coagulação (formação do gel): trombina + cloreto de cálcio x cloreto de cálcio. In: Pontual MAB, Magini RS (eds) Plasma rico em plaquetas e fatores de crescimento, da pesquisas científicas à clínica odontológica. Santos Editora, São Paulo, pp 233–257Google Scholar
  150. Lenharo A, Cosso F, Magalhães D et al (2004) Plasma rico em plaquetas–PRP. In: Pontual MAB, Magini RS (eds) Plasma rico em plaquetas e fatores de crescimento, da pesquisas científicas à clínica odontológica. Santos Editora, São Paulo, pp 163–186Google Scholar
  151. Levy O, Martinowitz U, Oran A et al (1999) The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am 81(11):1580–1588Google Scholar
  152. Li Y, Huard J (2002) Differentiation of muscle-derived cells into myofibroblasts in injured skeletal muscle. Am J Pathol 161(3):895–907Google Scholar
  153. Lin SS, Landesberg R, Chin HS et al (2006) Controlled release of PRP-derived growth factors promotes osteogenic differentiation of human mesenchymal stem cells. Conf Proc IEEE Eng Med Biol Soc 1:4358–4361Google Scholar
  154. Lind M (1988) Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies and implants fixation. Acta Orthop Scand Suppl 283:2–37Google Scholar
  155. Loo WL, Lee DY, Soon MYH (2009) Plasma rich in growth factors to treat adductor longus tear. Ann Acad Med 38(8):733–734Google Scholar
  156. Lopez-Vidriero E, Goulding KA, Simon DA et al (2010) The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy 26(2):269–278Google Scholar
  157. Lorenz HP, Longaker MT (2001) Wounds: biology, pathology, and management. In: Norton JA, Bollinger RR, Chang AE et al (eds) Surgery: basic science and clinical evidence. Springer, New York, pp 77–88Google Scholar
  158. Lotz JC, Haughton V, Boden SD, An HS, Kang JD, Masuda K, Freemont A, Berven S, Sengupta DK, Tanenbaum L, Maurer P, Ranganathan A, Alavi A, Marinelli NL (2012) New treatments and imaging strategies in degenerative disease of the intervertebral disks. Radiology 264(1):6–19Google Scholar
  159. Lyras DN, Kazakos K, Verettas D et al (2009) The effect of platelet-rich plasma gel in the early phase of patellar tendon healing. Arch Orthop Trauma Surg 129(11):1577–1582Google Scholar
  160. Maes C, Carmeliet P, Moermans K et al (2002) Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mach Dev 111(1–2):61–73Google Scholar
  161. Margolis DJ, Kantor J, Santanna J et al (2001) Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 24(3):483–488Google Scholar
  162. Marx RE (1999) Platelet-rich plasma: a source of multiple autologous growth factors for bone grafts. In: Lynch SE et al (eds) Tissue engineering, applications in maxillofacial surgery and peiodontics. Quintessence Books, Carol Stream pp 71–82Google Scholar
  163. Marx RE, Garg AK (2011) Applications of PRP in oral and maxillofacial surgery. Accessed 30 May 2011
  164. Matras H, Dinges H, Lassmann H et al (1972) Zur Nahtlosen interfaszikularen nerven transplantation im tierexperiment. Wein Med Wochenschr 122(37):517–523Google Scholar
  165. Matsumoto K, Nakamura T (1992) Hepatocyte growth factor: molecular structure, roles in liver regeneration and other biological functions. Crit Ver Oncog 3(1–2):27–54Google Scholar
  166. Mazzucco L, Medici D, Serra M et al (2004) The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion 44(7):1013–1018Google Scholar
  167. McCoy TH, Fehring TK, Larsen PY (2005) A retrospective analysis of the efficacy of autolo-gous platelet gel in total knee arthroplasty. Paper 433. In: American Academy of Orthopaedic Surgeons, Annual Meeting, Washington, 2005Google Scholar
  168. Mei-Dan O, Carmont M, Kots E et al (2010a) Early return to play following complete rupture of the medial collateral ligament of the elbow using preparation rich in growth factors: a case report. J Shoulder Elbow Surg 19(5):e1–e5Google Scholar
  169. Mei-Dan O, Mann G, Maffulli N (2010b) Platelet-rich plasma: any substance into it? Br J Sports Med 44(9):618–619Google Scholar
  170. Menetrey J, Kasemkijwattana C, Day C et al (2000) Growth factors improve muscle healing in vivo. J Bone Joint Surg Br 82(1):131–137Google Scholar
  171. Minami T, Horiuchi K, Miura M et al (2004) Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279(48):50537–50554Google Scholar
  172. Mishra A (2010) Mishra platelet rich plasma classification. Accessed 23 Apr 2011
  173. Mishra A, Pavelko T (2006) Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 34(11):1774–1778Google Scholar
  174. Mishra A, Tummala P, King A et al (2009a) Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C 15(3):431–435Google Scholar
  175. Mishra A, Woodall J, Vieira A (2009b) Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med 28(1):113–125Google Scholar
  176. Miyazawa T, Matsumoto K, Ohmichi H et al (1998) Protection of hippocampal neurons from ischemia-induced delayed neuronal death by hepatocyte growth factor: a novel neurotrophic factor. J Cereb Blood Flow Metab 18(4):345–348Google Scholar
  177. Molloy T, Wang Y, Murrell G (2003) The roles of growth factors in tendon and ligament healing. Sports Med 33(5):381–394Google Scholar
  178. Moojen DJ, Everts PA, Schure RM et al (2008) Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res 26:404–410Google Scholar
  179. Motley TA, Clements JR, Pourciau JK (2009) Incorporating platelet rich plasma and platelet poor plasma into open reduction internal fixation of closed caneus fractures to reduce wound complication: a case study. Foot Ankle Online J 2(11):1–5Google Scholar
  180. Murray MM, Rice K, Wright RJ et al (2003) The effect of selected growth factors on human anterior cruciate ligament cell interactions with a three-dimensional collagen-GAG scaffold. J Orthop Res 21(2):238–244Google Scholar
  181. Murray MM, Spindler KP, Abreu E et al (2007) Collagen-platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament. J Orthop Res 25(1):81–91Google Scholar
  182. Murray MM, Palmer M, Abreu E et al (2009) Platelet-rich plasma alone is not sufficient to enhance suture repair of the ACL in skeletally immature animals: an in vivo study. J Orthop Res 27(5):639–645Google Scholar
  183. Napolitano M, Matera S, Bossio M, Crescibene A, Costabile E, Almolla J, Almolla H, Togo F, Giannuzzi C, Guido G (2012) Autologous platelet gel for tissue regeneration in degenerative disorders of the knee. Blood Transfus 10(1):72–77. doi: 10.2450/2011.0026-11 Google Scholar
  184. Nin JRV, Gasque GM, Azcarate AV et al (2009) Has platelet-rich plasma any role in anterior cruciate ligament allograft healing? Arthroscopy 25(11):1206–1213Google Scholar
  185. Obata S, Akeda K, Imanishi T, Masuda K, Bae W, Morimoto R, Asanuma Y, Kasai Y, Uchida A, Sudo A (2012) Effect of autologous platelet-rich plasma-releasate on intervertebral disc degeneration in the rabbit anular puncture model: a preclinical study. Arthritis Res Ther. 14(6):R241 [Epub ahead of print]Google Scholar
  186. Orrego M, Larrain C, Rosales J et al (2008) Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy 24(12):1373–1380Google Scholar
  187. Osti OL, Fraser RD (1992) MRI and discography of annular tears and intervertebral disc degeneration. A prospective clinical comparison. J Bone Joint Surg Br 74-B:431–435Google Scholar
  188. Osti OL, Vernon-Roberts B, Moore R, Fraser RD (1992) Annular tears and disc degeneration in the lumbar spine. A post-mortem study of 135 discs. J Bone Joint Surg Br 74(5):678–682Google Scholar
  189. Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A (2013) Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 41(2):356–364Google Scholar
  190. Peerbooms JC, Sluimer J, Bruijn DJ et al (2010) Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med 38(2):255–262Google Scholar
  191. Pei M, Seidel J, Vunjak-Novakovic G, Freed LE (2002) Growth factors for sequential cellular de- and redifferentiation in tissue engineering. Biochem Biophys Res Commun 294(1):149–154Google Scholar
  192. Petrera M, de Cross A JN, Kandel RA et al (2011) Effects of platelet-Rich Plasma on tissue-engineered cartilage: a preliminary study. ICRS Newslett 13:35Google Scholar
  193. Pietrzak WS, Eppley BL (2005) Platelet rich plasma: biology and new technology. J Craniofac Surg 16(6):1043–1054Google Scholar
  194. Prins HJ, Rozemuller H, Slaper-Cortenbach I et al (2011) Human platelet lysate as substitute for fetal bovine serum for culture expansion of mesenchymal stromal cells in tissue engineering applications. ICRS Newslett (13):34Google Scholar
  195. Purita J (2011) My experience with PRP 1. ICRS Newslett (13):30Google Scholar
  196. Radice F, Yánez R, Gutiérrez V et al (2010) Comparison of magnetic resonance imaging findings in anterior cruciate ligament grafts with and without autologous platelet-derived growth factors. Arthroscopy 26(1):50–57Google Scholar
  197. Randelli P, Arrigoni P, Ragone V et al (2011) Platelet Rich Plasma (PRP) in arthroscopic rotator cuff repair. A prospective RCT study, 2 years follow-up. JSES 20(4):518–528Google Scholar
  198. Ranly DM, Lohmann CH, Andreacchio D et al (2007) Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. J Bone Joint Surg Am 89(1):139–147Google Scholar
  199. Redler LH, Thompson SA, Hsu SH et al (2011) Platelet-rich plasma therapy: a systematic literature review and evidence for clinical use. Phys Sportsmed 39(1):42–51Google Scholar
  200. Rees RS, Robson MC, Smiell JM et al (1999) Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study. Wound Rep Reg 7(3):141–147Google Scholar
  201. Rha DW, Park GY, Kim YK, Kim MT, Lee SC (2013) Comparison of the therapeutic effects of ultrasound-guided platelet-rich plasma injection and dry needling in rotator cuff disease: a randomized controlled trial. Clin Rehabil 27(2):113–122. doi: 10.1177/0269215512448388 Google Scholar
  202. Robiony M, Polini F, Costa F et al (2002) Osteogenesis distraction and platelet-rich plasma for bone restoration of the severely atrophic mandible: preliminary results. J Oral Maxillofac Surg 60(6):630–635Google Scholar
  203. Rodeo SA, Potter HG, Kawamura S et al (2007) Biologic augmentation of rotator cuff tendon-healing with use of a mixture of osteoinductive growth factors. J Bone Joint Surg Am 89(11):2485–2497Google Scholar
  204. Roussy Y, Bertrand Duchesne MP, Gagnon G (2007) Activation of human platelet-rich plasmas: effect on growth factors release, cell division and in vivo bone formation. Clin Oral Implants Res 18(5):639–648Google Scholar
  205. Rughetti A, Flamini S, Colafarina O et al (2004) Closed surgery: autologous platelet gel for the treatment of pseudoarthrosis. Blood Transfus 2:37–43Google Scholar
  206. Sacchi MC, Maresca P, Tartuferi L et al (2000) Platelet gel as a new routine method to improve wound healing and tissue regeneration. Transfus Med 10(4):325–325(1)Google Scholar
  207. Saldalamacchia G, Lapice E, Cuomo V et al (2004) A controlled study of the use of autologous platelet gel for the treatmentof diabetic foot ulcers. Nutr Metab Cardiovasc Dis 14:395–396Google Scholar
  208. Sampson S, Reed M, Silvers H, Meng M, Mandelbaum B (2010) Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil 89(12):961–969Google Scholar
  209. Sampson S, Aufiero D, Meng M et al (2011) Platelet-rich plasma therapy as a firstline treatment for severe Achilles tendon tear: a case report. Int J Ther Rehabil 18(2):101–106Google Scholar
  210. Sánchez M, Azofra J, Aizpurua B et al (2003a) Use of autologous plasma rich in growth factors in arthroscopic surgery. Cuader Artroscopia 10:12–19Google Scholar
  211. Sánchez M, Azofra J, Anitua E et al (2003b) Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc 35(10):1648–1652Google Scholar
  212. Sanchez M, Azofra J, Anitua E et al (2003c) Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc 35(10):1648–1652Google Scholar
  213. Sánchez M, Anitua E, Andia I (2005) Application of autologous growth factors on skeletal muscle healing. Regmed. Poster Presentation. Accessed 13 Apr 2011
  214. Sánchez M, Anitua E, Azofra J et al (2007) Comparison of surgically repaired achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med February 35(2):245–251Google Scholar
  215. Sánchez M, Anitua E, Azofra J et al (2008) Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol 26(5):910–913Google Scholar
  216. Sánchez M, Anitua E, Cugat R et al (2009) Nonunions treated with autologous preparation rich in growth factors. J Orthop Trauma 23(1):52–59Google Scholar
  217. Sánchez M, Anitua E, Azofra J et al (2010) Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: gross morphology and histology. Arthroscopy 26(4):470–480Google Scholar
  218. Sánchez M, Fiz N, Azofra J, Usabiaga J, Aduriz Recalde E, Garcia Gutierrez A, Albillos J, Gárate R, Aguirre JJ, Padilla S, Orive G, Anitua E (2012a) A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy 28(8):1070–1078Google Scholar
  219. Sánchez M, Guadilla J, Fiz N, Andia I (2012b) Ultrasound-guided platelet-rich plasma injections for the treatment of osteoarthritis of the hip. Rheumatology (Oxford) 51(1):144–150Google Scholar
  220. Savarino L, Cenni E, Tarabusi C et al (2006) Evaluation of bone healing enhancement by lyophilized bone grafts supplemented with platelet gel: a standardized methodology in patients with tibial osteotomy for genu varus. J Biomed Mater Res B Appl Biomater 76(2):364–372Google Scholar
  221. Schepull T, Kvist J, Norrman H et al (2011) Autologous platelets have no effect on the healing of human Achilles tendon ruptures: a randomized single-blind study. Am J Sports Med 39(1):38–47Google Scholar
  222. Schnabel LV, Mohammed HO, Miller BJ et al (2007) Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 25(2):230–240Google Scholar
  223. Scioli M (2006) Treatment of recalcitrant enthesopathy of the hip with platelet rich plasma—a report of three cases. Clinical Orthopaedic Society News. Accessed 24 May 2011
  224. Shen W, Prisk V, Li Y et al (2006) Inhibited skeletal muscle healing in cyclooxygenase-2 gene-deficient mice: the role of PGE2 and PGF2alpha. J Appl Phys 101(4):1215–1221Google Scholar
  225. Shen W, Li Y, Zhu J et al (2008) Interaction between macrophages, TGF-beta1, and the COX-2 pathway during inflammatory phase of skeletal muscle healing after injury. J Cell Physiol 214(2):405–412Google Scholar
  226. Siclari A (2011) The PRP in the repair of cartilage lesions. ICRS Newslett 13:25Google Scholar
  227. Silva A, Sampaio R (2009) Anatomic ACL reconstruction: does the platelet-rich plasma accelerate tendon healing? Knee Surg Sports Traumatol Arthrosc 17(6):676–682Google Scholar
  228. Simman R, Hoffmann A, Bohinc J et al (2008) Role of platelet-rich plasma in acceleration of bone fracture healing. Ann Plast Surg 61(3):337–344Google Scholar
  229. Smith JJ, Ross MW, Smith RK (2006) Anabolic effects of acellular bone marrow, platelet rich plasma, and serum on equine suspensory ligament fibroblasts in vitro. Vet Comp Orthop Traumatol 19(1):43–47Google Scholar
  230. Smith C, Kruger MJ, Smith RM et al (2008) The inflammatory response to skeletal muscle injury: illuminating complexities. Sports Med 38(11):947–969Google Scholar
  231. Soler Rich R, Soler F, Peirau X et al (2011) My experience with PRP 2. ICRS Newslett 13:31Google Scholar
  232. Souza MH (2005) Elias DO (2005) Manual de Instrução Programada: Princípios de Hematologia e Hemoterapia, 2nd edn. Centro de Estudos de Circulação Extracorpórea, Centro de Estudos Alfa Rio, Alfa RioGoogle Scholar
  233. Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A (2012) Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil [Epub ahead of print]Google Scholar
  234. Staindl O (1981) Surgical management of rhinophyma. Acta Otolaryngol 92:137–140Google Scholar
  235. Staindl O, Galvan G, Macher M (1981) The influence of fibrin stabilization and fibrinolysis on the fibrin-adhesive system. A clinical study using radioactively marked fibrinogen as a tracer. Arch Otorhinolaryngol 233(1):105–116Google Scholar
  236. Stütz H (2004) The use of autologous fibrin glue to reduce perioperative blood loss in total knee arthroplasty: results of a controlled study. Orthopädische Praxis 40(12):1–3Google Scholar
  237. Tabata Y (2003) Tissue regeneration based on growth factors release. Tissue Eng 9(1):880–886Google Scholar
  238. Tang YQ, Yeaman MR, Selsted ME (2002) Antimicrobial peptides from human platelets. Infect Immun 70(12):6524–6533Google Scholar
  239. Tate KS, Crane DM (2010) Platelet rich plasma grafts in musculoskeletal medicine. J Prolother 2(2):371–376Google Scholar
  240. Tidball JG (2005) Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 288(2):R345–R353Google Scholar
  241. Tidball JG, Wehling-Henricks M (2007) Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo. J Physiol 578(Pt 1):327–336Google Scholar
  242. Toumi H, Best TM (2003) The inflammatory response: friend or enemy for muscle injury? Br J Sports Med 37(4):284–286Google Scholar
  243. Trippel SB (1997) Growth factors as therapeutic agents. Instr Course Lect 46:473–476Google Scholar
  244. Trowbridge CC, Stammers AH, Woods E et al (2005) Use of platelet gel and its effects on infection in cardiac surgery. J Extra Corpor Technol 37(4):381–386Google Scholar
  245. van Buul GM, Koevoet WL, Kops N, Bos PK, Verhaar JA, Weinans H, Bernsen MR, van Osch GJ (2011) Platelet rich plasma inhibits IL-1b induced processes in osteoarthritic chondrocytes. ICRS Newslett 13:37Google Scholar
  246. van Susante J, Buma P, Schuman L et al (1999) Resurfacing potential of heterologous chondrocytes suspended in fibrin glue in large full-thickness defects of femoral articular cartilage: an experimental study in the goat. Biomaterials 20(13):1167–1175Google Scholar
  247. van Trommel MF, Simonian PT, Potter HG et al (1998) Arthroscopic meniscal repair with fibrin clot of complete radial tears of the lateral meniscus in the avascular zone. Arthroscopy 14(4):360–365Google Scholar
  248. Vendramin FS, Franco D, Franco TR (2010a) Utilização do plasma rico em plaquetas autólogo nas cirurgias de enxertos cutâneos em feridas crônicas. Rev Bras Cir Plást 25(4):589–594Google Scholar
  249. Vendramin FS, Franco D, Schamall RF et al (2010b) Utilização do plasma rico em plaquetas (PRP) autólogo em enxertos cutâneos em coelhos. Rev Bras Cir Plást 25(1):4–10Google Scholar
  250. Ventura A, Terzaghi C, Borgo E et al (2005) Use of growth factors in ACL surgery: preliminary study. J Orthopaed Traumatol 6(2):76–79Google Scholar
  251. Verdonk p, Dhollander A (2011) Early experience of Autologous Matrix Induced Chondrogenesis (AMIC) combined with platelet rich plasma gel (PRP) for the treatment of patellar cartilage defects in the knee. ICRS Newslett 13:26Google Scholar
  252. Videman T, Nurminen M (2004) The occurrence of anular tears and their relation to lifetime back pain history: a cadaveric study using barium sulfate discography. Spine (Phila Pa 1976), 29(23):2668–2676Google Scholar
  253. Vogrin M, Rupreht M, Crnjac A et al (2010) The effect of platelet-derived growth factors on knee stability after anterior cruciate ligament reconstruction: a prospective randomized clinical study. Wien Klin Wochenschr 122(2):91–95Google Scholar
  254. WADA (2013) The world anti-doping code: the 2013 prohibited list. International Standard, Montreal 2013Google Scholar
  255. Wang-Saegusa A, Cugat R, Ares O, Seijas R, Cuscó X, Garcia-Balletbó M (2010) Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg 131(3):311–317. doi: 10.1007/s00402-010-1167-3 Google Scholar
  256. Watson JT (2013) Autologous growth factors combined with demineralized bone matrix used as an alternative to autograft for the treatment of recalcitrant nonunited fractures of long bones: a report of six cases. DePuy Orthopaedics and DePuy ACE. Accessed 16 May 2013
  257. Webber RJ, Harris MG, Hough AJ Jr (1985) Cell culture of rabbit meniscal fibrochondrocytes: proliferative and synthetic response to growth factors and ascorbate. J Orthop Res 3(1):36–42Google Scholar
  258. Weibrich G, Kleis WK, Hafner G et al (2002) Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30(2):97–102Google Scholar
  259. West TB, Alster TS (1998) Autologous human collagen and dermal fibroblasts for soft tissue augmentation. Dermatol Surg 24(5):510–512Google Scholar
  260. Whitman DH, Berr YRL, Green DM (1977) Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Surg 55(11):1294–1299Google Scholar
  261. Woodell-May JE, Pietrzak WS (2008) Platelet-rich plasma in orthopedics. In: Pietrzak WS (ed) Orthopedic biology and medicine: musculoskeletal tissue regeneration, biological materials and methods. Humana Press, Totowa, pp 547–568Google Scholar
  262. Woodell-May J, O’Shaughnessey K, Matuska A et al (2011) Anti-inflammatory properties of platelet-rich plasma. ICRS Newslett 13:36Google Scholar
  263. Wright-Carpenter T, Klein P, Schäferhoff P et al (2004) Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med 25(8):588–593Google Scholar
  264. Wroblewski AP, Mejia HA, Wright VJ et al (2010) Application of platelet-rich plasma to enhance tissue repair. Oper Tech Orthop 20(2):98–105Google Scholar
  265. Yuan NB, Wang C, Wang Y et al (2007) The preliminary application of autologous platelet-rich gel used to treat refractory diabetic dermal ulcer. Sichuan Da Xue Xue Bao Yi Xue Ban 38(5):900–903MathSciNetGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • José F. Lana
    • 1
    Email author
  • Adam Weglein
    • 2
  • Eduardo Vicente
    • 1
  • Amanda G. M. Perez
    • 3
  • Ana A. Rodrigues
    • 4
  • Ângela C. M. Luzo
    • 5
  • Maria H. A. Santana
    • 3
  • William D. Belangero
    • 4
  1. 1.Research Institute of Sports MedicineOrthopedics and Regeneration-iMORUberabaBrazil
  2. 2.University of Texas Health Science Center at Houston Medical SchoolHoustonUSA
  3. 3.Department of Materials and Bioprocesses Engineering, School of Chemical EngineeringUniversity of CampinasCampinasBrazil
  4. 4.Department of Orthopaedic and Traumatology, Faculty of Medical SciencesUniversity of CampinasCampinasBrazil
  5. 5.Haematology and Hemotherapy CenterUmbilical Cord Blood Bank, University of CampinasCampinasBrazil

Personalised recommendations